Preceptorship on Colorectal Cancer 2014

Oncology Meeting Resources

22 May - 23 May, Prague, Czech Republic

ESMO Preceptorship on Colorectal Cancer

On this page, you may download the PDF or view the webcasts of presentations given at the Preceptorship on Colorectal Cancer 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Search Meeting Resources by Keyword

Useful links

Presenter Presentation title Session title
Jean-Yves Douillard Welcome Session 1 - Early colorectal cancer
Isabel Pimentel Case presentation: Long survival stage IV Colon Cancer Session 2 - Clinical cases
Pierre Laurent-Puig Microsatellite instability: Where do we stand? How useful is it? Session 3 - Adjuvant settings of colorectal cancer
Claus-Henning Köhne Adjuvant treatment for colon cancer stage III Session 3 - Adjuvant settings of colorectal cancer
Jean-Yves Douillard Adjuvant treatment of stage II: Which patients to treat? Session 3 - Adjuvant settings of colorectal cancer
Mark Saunders State‐of‐the‐art: Standard(s) of perioperative radio/chemotherapy for rectal cancer Session 4 - Metastatic colorectal cancer, liver limited metastases
Jean-Yves Douillard Review of the ESMO consensus conference on metastatic colorectal cancer Session 4 - Metastatic colorectal cancer, liver limited metastases
Claus-Henning Köhne Unresectable or borderline resectable (Group 1) chemotherapy +/- targetd agents Session 4 - Metastatic colorectal cancer, liver limited metastases
Pompiliu Piso Treatment of metastatic disease confined to the peritoneum Session 5 - Special clinical situations: Mono- or oligometastatic disease
Fotios Loupakis Management of treatment related side effects Session 5 - Special clinical situations: Mono- or oligometastatic disease
Claus-Henning Köhne This house believes that all RAS wt patients should be treated with EGFR inhibitors plus chemotherapy in first line Session 6 - Metastatic colorectal cancer I
Jean-Yves Douillard This house believes that all patients should be treated with VEGF inhibitors plus chemotherapy in first line and beyond progression Session 6 - Metastatic colorectal cancer I
Werner Scheithauer The role of maintenance, appropriate endpoints according to ESMO consensus Session 6 - Metastatic colorectal cancer I
Jean-Yves Douillard What to do after progression Session 7 - Metastatic colorectal cancer II
David Malka Options of locoregional treatment of liver metastasis Session 7 - Metastatic colorectal cancer II